Hims & Hers Health, Inc. (HIMS)
Sector: Healthcare
Industry: Services-Offices & Clinics of Doctors of Medicine
Country: United States
Exchange: NYSE
Market cap: $6.53B
Hims & Hers, launched in 2017, is a telehealth platform that connects patients and healthcare providers to offer treatment options for specialties like erectile dysfunction, hair loss, skin care, mental health, and weight loss. Its offerings include generic, branded, and compounded prescription drugs as well as over-the-counter medicines, cosmetics, and supplements. The platform, which has more than 2 million subscribers, is available in all 50 states and certain European markets like the UK. It includes provider networks, electronic medical records, cloud pharmacy fulfillment, and personalization capabilities. Hims does not take insurance and only accepts payments directly from customers.
Latest financial period: June 30, 2026
Filed with the SEC: August 10, 2026
Estimated earnings date: November 2, 2026
Profit #1121 of 1483 companies
| | Jun 26 | Mar 26 | Dec 25 | Sep 25 |
|---|
| ROE/ROA | 22.2% | 57.5% | 84.1% | 83.6% |
Growth #431 of 1483 companies
Payout #789 of 1483 companies
Safety #1243 of 1483 companies
Price #1331 of 1483 companies
